Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other Working Capital Changes (2016 - 2025)

Standard Biotools (LAB) has disclosed Other Working Capital Changes for 16 consecutive years, with -$2.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes fell 98.46% to -$2.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$4.5 million, a 20.12% increase, with the full-year FY2024 number at -$4.1 million, down 331.56% from a year prior.
  • Other Working Capital Changes was -$2.8 million for Q3 2025 at Standard Biotools, down from -$2.3 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $2.4 million in Q2 2021 to a low of -$4.4 million in Q2 2024.
  • A 5-year average of -$673052.6 and a median of -$901000.0 in 2023 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: surged 369.58% in 2021, then plummeted 3022.83% in 2022.
  • Standard Biotools' Other Working Capital Changes stood at -$2.2 million in 2021, then soared by 51.86% to -$1.1 million in 2022, then fell by 11.24% to -$1.2 million in 2023, then surged by 123.01% to $271000.0 in 2024, then tumbled by 1147.23% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Other Working Capital Changes are -$2.8 million (Q3 2025), -$2.3 million (Q2 2025), and $385000.0 (Q1 2025).